InvestorsHub Logo
Followers 38
Posts 8581
Boards Moderated 1
Alias Born 03/01/2015

Re: None

Thursday, 09/29/2022 9:24:18 AM

Thursday, September 29, 2022 9:24:18 AM

Post# of 329597
Very proud of our team, our Q-submission for our new Device RecoveryRX XTRA was received by the FDA. This
platform has proven to reduce opioid consumption by 60% during the post op period and improve functionality and participation in PT&Rehab. As we have talked with potential partners, opportunity clearly exists in the orthopedic, breast augmentation and reconstruction spaces and all types of same day cases. We are continuing to disrupt the pain space with neuromodulation innovation, with no side effects, no interactions and efficacy. Thanks to our growing list of KOLS whose help has been incredible. #innovation #team #opportunity




BUY $BIEL$